newsfeed-en
@SachsAssociates
8. Sep 2020 via Twitter
Isaac Bright, CEO will be presenting RubrYc Therapeutics, Inc. at the upcoming Biotech in Europe Forum.e-Meet RubrYc Therapeutics, Inc. at #Sachs_BEFMore info @ https://t.co/XI3zEYGyl2 pic.twitter.com/LmFOUZPnzb— Sachs Associates (@SachsAssociates) September 8, 2020
@SachsAssociates
8. Sep 2020 via Twitter
Francois R. Martelet, CEO will be presenting Oasmia Pharmaceutical AB at the upcoming Biotech in Europe Forum.e-Meet Oasmia Pharmaceutical AB at #Sachs_BEFMore info @ https://t.co/XI3zEYGyl2 pic.twitter.com/Ub4nuAN2ab— Sachs Associates (@SachsAssociates) September 8, 2020
@SachsAssociates
8. Sep 2020 via Twitter
e-Meet Laurent at #Sachs_BEFMore info @ https://t.co/XI3zEYGyl2 pic.twitter.com/zVwTlBNkIN— Sachs Associates (@SachsAssociates) September 8, 2020
@SachsAssociates
8. Sep 2020 via Twitter
Sebastien Petitet, CCO will be presenting Brenus Pharma at the upcoming Biotech in Europe Forum.e-Meet Brenus Pharma at #Sachs_BEFMore info @ https://t.co/XI3zEYGyl2 pic.twitter.com/qSVwAYI2ZV— Sachs Associates (@SachsAssociates) September 8, 2020
@SachsAssociates
8. Sep 2020 via Twitter
Dr. Ted FjÀllman Fjallman is the CEO of Prokarium, a London-based biotech developing microbial immunotherapy and vaccines.e-Meet Ted at #Sachs_BEFMore info @ https://t.co/XI3zEYGyl2 pic.twitter.com/8Leoa6OEFR— Sachs Associates (@SachsAssociates) September 8, 2020
@SachsAssociates
8. Sep 2020 via Twitter
Juergen Gamer, VP Business Development will be presenting Apogenix AG at the upcoming Biotech in Europe Forum.e-Meet Apogenix AG at #Sachs_BEFMore info @ https://t.co/XI3zEYGyl2 pic.twitter.com/HvkyxUTDR8— Sachs Associates (@SachsAssociates) September 8, 2020
@SachsAssociates
7. Sep 2020 via Twitter
e-Meet Shayne Kennedy from @lathamwatkins at #Sachs_BEFMore info @ https://t.co/XI3zEYGyl2 pic.twitter.com/9UjTRdHfp8— Sachs Associates (@SachsAssociates) September 7, 2020
@SachsAssociates
7. Sep 2020 via Twitter
Austin Speier is Chief Strategy Officer at Click Therapeutics, where he works to align product development, go-to-market and regulatory strategy for Click's pipeline of digital therapeutics.e-Meet Austin at #Sachs_BEFMore info @ https://t.co/XI3zEYGyl2 pic.twitter.com/0vRMPGWkl1— Sachs Associates (@SachsAssociates) September 7, 2020
@SachsAssociates
7. Sep 2020 via Twitter
e-Meet Microbiotica Ltd. at #Sachs_BEFMore info @ https://t.co/XI3zEYGyl2 pic.twitter.com/jl4tDzDGtY— Sachs Associates (@SachsAssociates) September 7, 2020
@SachsAssociates
7. Sep 2020 via Twitter
e-Meet MedinCell S.A. at #Sachs_BEFMore info @ https://t.co/XI3zEYGyl2 pic.twitter.com/GPHuHCnb2o— Sachs Associates (@SachsAssociates) September 7, 2020